CSIMarket
 
Greenlight Biosciences Holdings Pbc  (NASDAQ: GRNA)
 
Price: $0.0000 $0.00 %
Day's High: 0.00 Week Perf:
Day's Low: $ 0.00 30 Day Perf:
Volume (M): 0 52 Wk High: $ 0.00
Volume (M$): $ 0 52 Wk Avg: $0.00
Open: $0.00 52 Wk Low: $0.00



 Market Capitalization (Millions $) -
 Shares Outstanding (Millions) 152
 Employees 143
 Revenues (TTM) (Millions $) 10
 Net Income (TTM) (Millions $) -157
 Cash Flow (TTM) (Millions $) -51
 Capital Exp. (TTM) (Millions $) 28

Business Description


Greenlight Biosciences Holdings Pbc is a biotechnology company that specializes in developing sustainable and environmentally friendly solutions for agriculture, energy, and healthcare sectors. The company focuses on harnessing the power of biology to address global challenges such as food production, carbon emissions, and disease control.

Greenlight Biosciences utilizes a proprietary platform called Cell-Free Biology that enables them to efficiently produce high-quality RNA, which can be used to create a wide range of products. This technology allows the company to rapidly develop and scale their solutions, making their products cost-effective and accessible.

The company's focus areas include crop protection, where they develop RNA-based solutions to protect crops from pests and diseases, leading to increased yields and reduced use of chemical pesticides. In the energy sector, Greenlight Biosciences is working on sustainable and renewable solutions, including biofuels and sustainable products for industrial applications. In the healthcare field, the company is focused on developing RNA-based therapies and vaccines for diseases such as COVID-19 and cancer.

Greenlight Biosciences has partnerships with various organizations, including industry leaders and academic institutions, to advance their research and development efforts. They are committed to providing sustainable solutions that have a positive impact on the environment and human health.


   Company Address: 29 Hartwell Avenue Lexington 2421 MA
   Company Phone Number: 616-8188   Stock Exchange / Ticker: NASDAQ GRNA


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
AGEN   -14.14%    
AMGN   -10.69%    
BIIB   -2.46%    
ITOS   -0.39%    
SGEN        4.77% 
SURF      0% 
• View Complete Report
   





Fundamental Analysis

Valuation Current
Price to Earnings PE Ratio (TTM) -
Price to Earnings PE Ratio (Expected) -
Price to Sales (TTM) -
Price to Sales (Expected) -
Price to Book -
PEG (TTM) -

Financial Strength Current
Quick Ratio 1.04
Working Capital Ratio 1.21
Leverage Ratio (MRQ) 4.18
Total Debt to Equity 0.63
Interest Coverage (TTM) -
Debt Coverage (TTM) -

Per Share Current
Earnings (TTM) -1.17 $
Revenues (TTM) 0.07 $
Cash Flow (TTM) -
Cash 0.21 $
Book Value 0.14 $
Dividend (TTM) 0 $

Efficiency Current
Revenue per Employee (TTM) 72,329
Net Income per Employee (TTM) -1,100,119
Receivable Turnover Ratio (TTM) -
Inventory Turnover Ratio (TTM) -
Asset Turnover Ratio (TTM) 0.08

Profitability Ratios Current
Gross Margin (MRQ) -
Operating Margin (MRQ) -740.63 %
Net Margin (MRQ) -745.26 %
Net Cash Flow Margin (MRQ) -933.43 %
Effective Tax Rate (TTM) -

Management Effectiveness Current
Return On Assets (TTM) -
Return On Investment (TTM) -
Return On Equity (TTM) -
Dividend Yield -
Pay out Ratio (TTM) -






Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.